Treatment with RAP-011 also produced beneficial effects in a mouse model of myocardial infarction (Supplementary Figure 1), consistent with previously reported benefits of ActRIIB ligand inhibition under comparable conditions (20). The gene discussed is ACVR2B; the disease is myocardial infarction.